Journals / Turkish Studies (Elektronik) / 2020 / Cilt: 15 - Sayı: 4

Assessing of Factors Effecting COVID-19 Mortality Rate on a Global Basis

COVID-19 Ölüm Hızını Etkileyen Faktörlerin Küresel Bazda Değerlendirilmesi

Pages
1185–1192
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the results of the regression analysis for meaningful relationship variables, all independent variables affect the death/case ratio.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, it was aimed to investigate the effect of some health indicators of selected countries on COVID-19 pandemic death/case rates.
📊
Key Findings & Data:In this study, which was conducted using retrospective data, the health indicators of countries with more than 50,000 COVID-19 cases were compared with the COVID-19 cases and death rates in these countries.
💡
Conclusion & Impact:According to the results of the regression analysis for meaningful relationship variables, all independent variables affect the death/case ratio.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, it was aimed to investigate the effect of some health indicators of selected countries on COVID-19 pandemic death/case rates. In this study, which was conducted using retrospective data, the health indicators of countries with more than 50,000 COVID-19 cases were compared with the COVID-19 cases and death rates in these countries. The data used in the research process were obtained by the World Health Organization, the World Bank, and OECD sources. Results: Considering the findings obtained in the analysis, the USA ranks first in the highest number of deaths (89271), while Saudi Arabia is the last (329). The highest rate of death/case belongs to France (19.8), the lowest rate to Saudi Arabia (0.5%). In the correlation analysis based on the death/case ratio, a significant relationship was found in cancer deaths, congenital life expectancy, life expectancy above 65 years old, population 65 years and older (positive direction), and air pollution variables (negative direction). According to the results of the regression analysis for meaningful relationship variables, all independent variables affect the death/case ratio. The highest influencing variable is congenital life expectancy (R2 = ,462). As a result, deaths from cancer and especially congenital life expectancy and population over 65 years of age have a positive effect on COVID-19 death/case ratio. In this context, it is necessary to continue taking measures to protect the elderly population and individuals with chronic anxiety.

Özet

Bu çalışmada, seçilmiş ülkelerin bazı sağlık göstergelerinin COVID-19 pandemisi ölüm/vaka oranlarıüzerindeki etkisinin araştırılması amaçlanmıştır. Retrospektif veriler kullanılarak yapılan bu çalışmada,50.000'den fazla COVID-19 vakası olan ülkelerin sağlık göstergeleri ve bu ülkelerdeki ölüm oranları ile karşılaştırılmıştır. Araştırma sürecinde kullanılan veriler Dünya Sağlık Örgütü, Dünya Bankası ve OECDkaynakları tarafından elde edilmiştir. Analizden elde edilen bulgular göz önüne alındığında, ABD ölümsayısında (89271) birinci sırada yer alırken, Suudi Arabistan son sıradadır (329). En yüksek ölüm/vaka oranıFransa'ya (% 19,8), en düşük ölüm oranı ise Suudi Arabistan'a (% 0,5) aittir. Ölüm/vaka oranına dayalıkorelasyon analizinde kanser ölümleri, doğumdan yaşam beklentisi, 65 yaş üstü yaşam beklentisi, 65 yaş ve üstünüfus (pozitif yönde) ve hava kirliliği değişkenleri (negatif yönde) arasında anlamlı bir ilişki bulunmuştur.Anlamlı ilişki bulunan değişkenler için yapılan regresyon analizi sonuçlarına göre, tüm bağımsız değişkenlerölüm/vaka oranını etkilemektedir. En fazla etki eden değişken, doğumdan yaşam beklentisidir (R2 = ,462). Sonuç olarak kanserden ölümler ve özellikle doğumdan yaşam beklentisi ve 65 yaş üstü nüfus, COVID-19 ölümvaka oranları üzerinde olumlu bir etkiye sahiptir. Bu bağlamda, yaşlı nüfusu ve kronik anksiyetesi olan bireylerikorumak için önlemler almaya devam etmek gerekmektedir.

🔖

Cite This Article

UYSAL, B., DEMİRKIRAN, M., YORULMAZ, M. (2022). Assessing of Factors Effecting COVID-19 Mortality Rate on a Global Basis. Turkish Studies (Elektronik), Cilt: 15 - Sayı: 4, 1185–1192. https://ajindex.com/articles/617248

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Al-Ahdal, M.N., Al-Qahtani, A.A., & Rubino, S. (2012). Coronavirus respiratory illness in Saudi Arabia. The Journal of Infection in Developing Countries, 6(10), 692-694. https://doi.org/10.3855/jidc.3084
  2. Armitage, R., & Nellums, L.B. (2020). COVID-19 and the consequences of isolating the elderly. The Lancet. Public health, 5(5), e256. https://doi.org/10.1016/S2468-2667(20)30061-X
  3. Cascella, M., Rajnik, M., Cuomo, A., et al. (2020). Features, evaluation and treatment coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
  4. Chen, L., Xiong, J., Bao, L., & Shi, Y. (2020). Convalescent plasma as a potential therapy for COVID-19. The Lancet, 20(4), 398-400. https://doi.org/10.1016/S1473-3099(20)30141-9 European Centre for Disease Prevention and Control. (2020). Q & A on COVID-19. https://www.ecdc.europa.eu/en/covid-19/questions-answers
  5. Fung, T.S., & Liu, D.X. (2019). Human coronavirus: Host-pathogen interaction. Annual Review of Microbiology, 73, 529-557. https://doi.org/10.1146/annurev-micro-020518-115759 General Office of National Health Committee (2020). Office of State Administration of Traditional Chinese Medicine. Notice on the issuance of a programme for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 4). Gondauri, D., & Batiashvili, M. (2020). The study of the effects of mobility trends on the statistical models of the COVID-19 virus spreading. Electronic Journal of General Medicine, 17(6): em243. https://doi.org/10.29333/ejgm/8212
  6. Jin, Y.H., Cai, L., Cheng, Z.S., Cheng, H., Deng, T., Fan, Y.P., et al. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version), Military Medical Research, 7(4), 1-23. https://doi.org/10.1186/s40779- 020-0233-6
  7. Kelvin, D.J., & Rubino, S. (2020). Fear of the novel coronavirus. The Journal of Infection in Developing Countries, 14(1), 1-2. https://doi.org/10.3855/jidc.12496
  8. Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. (2020).
  9. Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine, 282(13), 1199-1207. https://doi.org/10.1056/NEJMoa2001316
  10. Murthy, S., Gomersall, C.D., & Fowler, R.A. (2020). Care for critically ill patients with COVID-19. JAMA, 323(15), 1499-1500. https://doi.org/10.1001/jama.2020.3633 OECD. (2020a). OECD Data. https://data.oecd.o